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Rhnbdonryolysis in acute Q fever 
Clin Minobiof Infect 1999; 5: 770-771 
Acute Q fever is a non-specific febrile illness caused by 
Cwciella burnetii. The most common clinical pre- 
sentations of acute C. burnetii infection are atypical 
pneumonia and hepatitis [l]. Other complications of 
acute Q fever include hemolytic anemia, myocarditis, 
pericarditis, pancreatitis, thyroiditis, mesenteric panni- 
culitis, mediastinal lymphadenopathy, orchitis, erythema 
nodosum and optic neuritis [2]. However, rhabdo- 
myolysis is an apparently uncommon complication of 
C. burnetii infection, and this association has rarely been 
reported [MI. Here we report another case of severe 
rhabdomyolysis secondary to acute Q fever. 
A 75-year-old man was admitted to our hospital 
because of a 24-36 h history of fmer, chills, malaise, 
myalgias and severe muscular weakness. He had had 
fiequent contact with livestock. On admission, temp- 
erature was 38.8"C and blood pressure 130180 mmHg. 
Physical examination was unremarkable. White blood 
cell count was 1O.7X1O9/L (76% neutrophils, 19% 
band forms, 1% lymphocytes, and 4% monocytes), 
hemoglobin level was 15 g/dL. and platelet count was 
133X 109/L. Laboratory tests revealed serum creatinine 
3.4 rng/dL, urea 193 mg/dL, creatine base 21835 
U/L (MB fraction 120U/L), lactate dehydmgenase 
679 U/L, aspartate aminotransferase 436 U/L, alanjne 
aminotransferase 165U/L, and a n o d  bilirubin 
value, Antinuclear antibodies, rheumatoid fiaor, and 
antineutrophil cytoplasmic antibodies were negative. 
Chest radiographs and thoracic and abdominal com- 
puted tomography were normal. Cultures ofblood and 
urine were sterile. Antibodies against C. bumetii were 
not determined during the hospitalization period. 
Therapy with doxacillin and cipmfloxacin was empi- 
rically started and was followed by a clear improvement 
in the patient's condition. He was discharged after 11 
days of treatment. One month later, the patient was 
asymptomatic and the abnormal laboratory tests had 
became normal. Serologic tests for Leptospira, Bnuella, 
syphilis and Borrelia burgdofm' were negative. The titer 
of IgG antibodies to phase I1 antigen of C. burnetii 
determined by the indirect immunofluorescence test 
(bioMerieux, Marcy l'Etoile, France) was 1/2048, and 
IgM antibodies were positive. Four months after the 
onset of symptoms the titer of antibodies had fallen to 
1/256. 
Although, unfortunately, seroconversion could not 
be confirmed in this patient because of the lack of an 
earlier serum sample, the positivity of Igh4 and the very 
high titer of IgG antibodies 45 days &er the onset of 
symptoms strongly suggest acute Q fever. In addition, 
the decrease in the titer of antibodies observed several 
months later suggests that the first determination 
corresponded to the peak titer of antibodies. Our 
patient presented with transient acute r e d  fiilure due 
to rhabdomyolysis, like one of the seven cases pre- 
viously reported [4]. Myoglobinuric renal failure, 
which complicates up to 30% of cases of rhabdo- 
myolysis, is the result of the toxic effects of myoglobin 
on tubule epithelial cells [9]. However, pathogenetic 
mechanisms of rhabdomyolysis in acute Q fwer are 
unclear. Nevertheless, some authors have suggested that 
rhabdomyolysis in these patients might be a conse- 
quence of release of an endotoxin or exotoxin [3]. 
It is interesting that all patients reported with 
muscle injury associated with acute Q fever, like our 
patient, were h m  Spain, considenng that there is no 
evidence that the Spanish strains of C. bumetii have a 
particular muscular tropism. However, the manifeta- 
tions of t h i s  infection may H e r  fi-om country to 
Correspondence 77 1 
country [l]. Alternatively, this apparent concentration 
of cases in Spain might be due to a high index of 
suspicion for the infection and its associated com- 
plications in a country that has a very high prevalence 
of C. burnetii infection [10-13]. 
We suggest that subclinical rhabdomyolysis may be 
more common than suspected in t h i s  infection, and 
that determination of muscular enzymes should be 
routinely performed in patients with acute Q fever. In 
addition, we believe that the possibility of C .  burnetii 
infection should be considered in the differential 
diagnosis of the febrile patient who presents with 
rhabdomyolysis, regardless of the presence or not of 
pulmonary infiltrates. 
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Quality control limits for antimicrobial susceptibility 
tests of cefpirome 
Clin Microbiol Infect 1999; 5: 771-773 
Cefpirome is a broad-spectrum cephalosporin [I ,2] that 
has been available for use in many countries for the past 
decade. The National Committee for Clinical Labora- 
tory Standards (NCCLS) selects interpretive criteria 
and quality control guidelines for susceptibility tests of 
antimicrobial agents that are marketed in the USA. 
Because US regulatory agencies have not yet con- 
sidered cefpirome for sale in the USA, the NCCLS 
has not been asked to include cefpirome in its tables. 
In November 1997, we performed a 10-laboratory 
collaborative study to define quality control limits for 
disk &sion and broth microdilution tests performed 
according to the current NCCLS methods. These 
studies include tests of Streptococcus pneumoniae ATCC 
49619, Haernophilus infuenzae ATCC 49247, Escherickia 
cofi ATCC 25922, Pseudomoms aetuginosa ATCC 27853, 
Staphylococcus aureus ATCC 25923 and Stapkylococcus 
aureus ATCC 29213. The result of this exercise is 
briefly described here for those who may want to test 
cefpirome by NCCLS methods. 
Commercially prepared 30-pg cefpirome disks 
(BDMS lot 707629 and Oxoid lot 46141) were 
evaluated in parallel. There were no differences in zone 
diameters produced by the two lots of disks, so the data 
were combined for analysis. Six different lots of 
Mueller-Hinton agar h m  four different manufacturers 
were included in the study design. The agar was pre- 
pared as Haemophilus Test Medium (HTM) [3] when 
testing H. inauenzae, and 5% defibrinated sheep blood 
was added to the Mueller-Hinton agars when testing 
Streptococcus pneumoniae. For broth microdilution tests, 
cefpirome was serially diluted in each of five lots of 
cation-adjusted Mueller-Hinton broth f?om three 
different manufacturers. The broth media were pre- 
pared as HTM [4] for testing the H. injuenzae strain or 
supplemented with 2-3% lysed horse blood for testing 
the pneumococcus. Cefotaxime was the control anti- 
biotic: for any day that a cefotaxime result was outside 
of established limits, a l l  cefpirome MIC or zone size 
data for that day were excluded h m  the analysis, even 
though the excluded data were well within the pro- 
posed limits for cefpirome. 
